178 related articles for article (PubMed ID: 32881152)
1. Salivary LDH in oral cancer and potentially malignant disorders: A systematic review and meta-analysis.
Iglesias-Velázquez Ó; López-Pintor RM; González-Serrano J; Casañas E; Torres J; Hernández G
Oral Dis; 2022 Jan; 28(1):44-56. PubMed ID: 32881152
[TBL] [Abstract][Full Text] [Related]
2. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
3. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.
Chiamulera MMA; Zancan CB; Remor AP; Cordeiro MF; Gleber-Netto FO; Baptistella AR
BMC Cancer; 2021 Feb; 21(1):205. PubMed ID: 33639868
[TBL] [Abstract][Full Text] [Related]
4. Salivary metabolomics in oral potentially malignant disorders and oral cancer patients-a systematic review with meta-analysis.
Nazar NSBM; Ramanathan A; Ghani WMN; Rokhani FB; Jacob PS; Sabri NEB; Hassan MS; Kadir K; Dharmarajan L
Clin Oral Investig; 2024 Jan; 28(1):98. PubMed ID: 38225483
[TBL] [Abstract][Full Text] [Related]
5. ABO Blood Groups and Its Association with Oral Cancer, Oral Potentially Malignant Disorders and Oral Submucous Fibrosis- A Systematic Review and Meta-Analysis.
Singh A; Purohit BM
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1703-1712. PubMed ID: 34181324
[TBL] [Abstract][Full Text] [Related]
6. Serum Lactate Dehydrogenase Enzyme as a Tumor Marker in Potentially Malignant Disorders: A Systematic Review and Meta-Analysis.
Barbi W; Purohit BM
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2553-2559. PubMed ID: 36037107
[TBL] [Abstract][Full Text] [Related]
7. Environmental heavy metal as a potential risk factor for the progression of oral potentially malignant disorders in central Taiwan.
Tsai KY; Su CC; Chiang CT; Tseng YT; Lian IB
Cancer Epidemiol; 2017 Apr; 47():118-124. PubMed ID: 28259083
[TBL] [Abstract][Full Text] [Related]
8. Salivary and serum levels of lactate dehydrogenase in oral submucous fibrosis: A meta-analysis.
Chen X; Chen T; Xie H; Guo J
Medicine (Baltimore); 2024 Apr; 103(15):e37788. PubMed ID: 38608075
[TBL] [Abstract][Full Text] [Related]
9. Association of salivary cortisol and psychological burden in patients with oral cancer and oral potentially malignant disorders: A prospective study.
Kumar S; Kumar K; Singh B; Mehrotra D; Mahdi AA
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147974
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of salivary micro RNA-21 and 31 in oral potentially malignant disorders.
Uma Maheswari TN; Nivedhitha MS; Ramani P
Braz Oral Res; 2020; 34():e002. PubMed ID: 32049107
[TBL] [Abstract][Full Text] [Related]
11. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis.
Mello FW; Miguel AFP; Dutra KL; Porporatti AL; Warnakulasuriya S; Guerra ENS; Rivero ERC
J Oral Pathol Med; 2018 Aug; 47(7):633-640. PubMed ID: 29738071
[TBL] [Abstract][Full Text] [Related]
13. Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis.
Ramos-García P; González-Moles MÁ; Warnakulasuriya S
Oral Oncol; 2022 Mar; 126():105734. PubMed ID: 35091134
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis.
Kallalli BN; Rawson K; Muzammil ; Singh A; Awati MA; Shivhare P
J Oral Pathol Med; 2016 Oct; 45(9):687-690. PubMed ID: 27132033
[TBL] [Abstract][Full Text] [Related]
15. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
[TBL] [Abstract][Full Text] [Related]
16. Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
Panda A; Behura SS; Bhuyan L; Dash KC; Kumar V; Mukherjee S
J Oral Maxillofac Pathol; 2020; 24(1):183. PubMed ID: 32508472
[TBL] [Abstract][Full Text] [Related]
17. Assessment of brush biopsy findings and salivary LDH levels in oral mucosal lesions of tobacco users.
Davidson SP; Kumar S; Somasundaram E; Jaishankar S
Indian J Dent Res; 2023; 34(2):191-195. PubMed ID: 37787211
[TBL] [Abstract][Full Text] [Related]
18. Study of the Role of Salivary Lactate Dehydrogenase in Habitual Tobacco Chewers, Oral Submucous Fibrosis and Oral Cancer as a Biomarker.
Mantri T; Thete SG; Male V; Yadav R; Grover I; Adsure GR; Kulkarni D
J Contemp Dent Pract; 2019 Aug; 20(8):970-973. PubMed ID: 31797856
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of lactate dehydrogenase enzyme activity in saliva and serum of oral submucous fibrosis patients.
Sivaramakrishnan M; Sivapathasundharam B; Jananni M
J Oral Pathol Med; 2015 Jul; 44(6):449-52. PubMed ID: 25224513
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus and oral cancer/oral potentially malignant disorders: A systematic review and meta-analysis.
Ramos-Garcia P; Roca-Rodriguez MDM; Aguilar-Diosdado M; Gonzalez-Moles MA
Oral Dis; 2021 Apr; 27(3):404-421. PubMed ID: 31994293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
